Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET
Sunil Thomas
Pathogens and Immunity (2020) Vol. 5, Iss. 1, pp. 342-342
Open Access | Times Cited: 157

Showing 1-25 of 157 citing articles:

Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
SARS‐CoV‐2, the pandemic coronavirus: Molecular and structural insights
Swapnil B. Kadam, Geetika S. Sukhramani, Pratibha Bishnoi, et al.
Journal of Basic Microbiology (2021) Vol. 61, Iss. 3, pp. 180-202
Open Access | Times Cited: 170
The glycosylation in SARS-CoV-2 and its receptor ACE2
Yanqiu Gong, Suideng Qin, Lunzhi Dai, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 166
Glycosylation of SARS-CoV-2: structural and functional insights
Asif Shajahan, Lauren E. Pepi, Daniel S. Rouhani, et al.
Analytical and Bioanalytical Chemistry (2021) Vol. 413, Iss. 29, pp. 7179-7193
Open Access | Times Cited: 76
A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence
Xianwen Zhang, Yang Liu, Jianying Liu, et al.
Cell (2021) Vol. 184, Iss. 8, pp. 2229-2238.e13
Open Access | Times Cited: 73
Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
Liliana Rodrigues, Renata Bento Cunha, Tatiana Vassilevskaia, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2723-2723
Open Access | Times Cited: 63
Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion
Anamica Hossain, Shammi Akter, Alfi Anjum Rashid, et al.
Microbial Pathogenesis (2022) Vol. 170, pp. 105699-105699
Open Access | Times Cited: 63
Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin
Mattia Miotto, Lorenzo Di Rienzo, Leonardo Bò, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 56
Review of COVID-19 Vaccines Approved in the United States of America for Emergency Use
Deepa Vasireddy, Paavani Atluri, Srikrishna V Malayala, et al.
Journal of Clinical Medicine Research (2021) Vol. 13, Iss. 4, pp. 204-213
Open Access | Times Cited: 56
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Peiran Chen, Mandi Wu, Yaqing He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 27
Protein post-translational modification in SARS-CoV-2 and host interaction
Nana Cheng, Mingzhu Liu, Wanting Li, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 26
After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives
Hazim O. Khalifa, Yousef Al Ramahi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 739-739
Open Access | Times Cited: 10
Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications
Li Shen, Jennifer Dien Bard, Timothy J. Triche, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 885-893
Open Access | Times Cited: 54
Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19
Janna Heide, Sophia Schulte, Matin Kohsar, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009842-e1009842
Open Access | Times Cited: 47
Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations
Faez Iqbal Khan, Tongzhou Kang, Haider Ali, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 44
Rice SUT and SWEET Transporters
Zhi Hu, Zhenjia Tang, Yanming Zhang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11198-11198
Open Access | Times Cited: 44
Progress in Electrochemical Biosensing of SARS-CoV-2 Virus for COVID-19 Management
Md. Mahbubur Rahman
Chemosensors (2022) Vol. 10, Iss. 7, pp. 287-287
Open Access | Times Cited: 31
SARS‐CoV‐2 infection and lytic reactivation of herpesviruses: A potential threat in the postpandemic era?
Jungang Chen, Jiao Song, Lu Dai, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5103-5111
Open Access | Times Cited: 28
COVID-19 Variants and Vaccine Development
Ziyao Zhao, Sahra Bashiri, Zyta M. Ziora, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 757-757
Open Access | Times Cited: 5
Transcription Kinetics in the Coronavirus Life Cycle
Katarzyna Grelewska‐Nowotko, Ahmed Eısa Elhag, Tomasz W. Turowski
Wiley Interdisciplinary Reviews - RNA (2025) Vol. 16, Iss. 1
Open Access
Synergistic Integration of Multimodal Modeling Approaches for Accelerated COVID-19 Therapeutic Development
Mayurika Goel, Kushal Gupta, Ishal Srivastava, et al.
Advances in Science, Technology & Innovation/Advances in science, technology & innovation (2025), pp. 195-210
Closed Access
Navigating COVID-19: advancements in therapeutics and viral filtration technologies for Today's challenges and tomorrow's solutions
Devesh U. Kapoor, Bhavna Kumar, Manmohan Singhal, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106741-106741
Closed Access
T-CELL IMMUNE RESPONSE TO SARS-COV-2 IN HEALTHCARE WORKERS 2.5-3 YEARS AFTER COVID-19
И. Д. Решетникова, Yury A. Tyurin, Р. С. Фассахов, et al.
Russian Journal of Allergy (2025)
Closed Access
Betacoronavirus Assembly: Clues and Perspectives for Elucidating SARS-CoV-2 Particle Formation and Egress
David Bracquemond, Delphine Muriaux
mBio (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 39
Artificial Intelligence in Vaccine and Drug Design
Sunil Thomas, Ann Abraham, Jeremy Baldwin, et al.
Methods in molecular biology (2021), pp. 131-146
Closed Access | Times Cited: 39
Page 1 - Next Page

Scroll to top